176 related articles for article (PubMed ID: 6101934)
1. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
[TBL] [Abstract][Full Text] [Related]
3. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
Olowoyeye JO; Thadani U; Parker JO
Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
Jackson G; Atkinson L; Oram S
Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
[TBL] [Abstract][Full Text] [Related]
5. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
Uusitalo AJ; Keyriläinen O
Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
Jones GR; Mir MA
Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
Keyriläinen O; Uusitalo A
Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
[TBL] [Abstract][Full Text] [Related]
8. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
Borer JS; Comerford MB; Sowton E
J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
[TBL] [Abstract][Full Text] [Related]
9. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adrenergic beta-receptor antagonists in angina pectoris.
Thadani U; Sharma B; Meeran MK; Majid PA; Whitaker W; Taylor SH
Br Med J; 1973 Jan; 1(5846):138-42. PubMed ID: 4145234
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic receptor blocking drugs in angina pectoris.
Prichard BN
Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
[No Abstract] [Full Text] [Related]
12. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
Taylor SH; Silke B; Lee PS
N Engl J Med; 1982 Mar; 306(11):631-5. PubMed ID: 6120457
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
14. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
[TBL] [Abstract][Full Text] [Related]
15. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
[TBL] [Abstract][Full Text] [Related]
16. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
Thadani U; Parker JO
Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
Sandler G; Clayton GA
Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
[TBL] [Abstract][Full Text] [Related]
18. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
[TBL] [Abstract][Full Text] [Related]
19. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
Keyriläinen O; Uustialo A
Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
